Immutep Ltd has released a press release.
Appendix 4E & 2017 Full Year Statutory Accounts
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Immutep
- French government research cash rebate of A$1.3M received
- Financial Update
- 2nd milestone payment to be received from Novartis
- Approvals received to initiate INSIGHT clinical trial
- Disclosure Under LR 3.10.5A and 7.1A.4(b)
Later from Immutep
- PRR & Monash Uni receive funding grant for LAG-3 Research
- Japanese Patent Grants For IMP321 In Infectious Disease
- Japanese Patent Grant for IMP731 Antibody
- European patent grant for IMP321 in cancer
- Immutep receives USD1M milestone payment from EOC
Follow Immutep into a list and get an email when it puts out news.
Follow Immutep